Literature DB >> 11407945

The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.

N Bardeesy1, N E Sharpless, R A DePinho, G Merlino.   

Abstract

Pancreatic cancer is among the leading causes of cancer death. Although a genetic profile for pancreatic cancer is emerging, many biological aspects of this disease are poorly understood. Indeed, fundamental questions regarding progenitor cell lineages, host stromal milieu, and the role of specific genetic alterations in tumor progression remain unresolved. A mouse model engineered with signature mutations would provide a powerful ally in the study of pancreatic cancer biology and may guide improved prognostic assessment and treatment for the human disease. In this review, we discuss the molecular basis for normal pancreatic development and the genetics of human pancreatic adenocarcinoma in the hope of charting a course for the development of a faithful mouse model for this lethal cancer. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11407945     DOI: 10.1006/scbi.2000.0371

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  12 in total

1.  Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia.

Authors:  Pierre-Paul Prévot; Alexandru Simion; Adrien Grimont; Marta Colletti; Abed Khalaileh; Géraldine Van den Steen; Christine Sempoux; Xiaobo Xu; Véronique Roelants; Jacob Hald; Luc Bertrand; Harry Heimberg; Stephen F Konieczny; Yuval Dor; Frédéric P Lemaigre; Patrick Jacquemin
Journal:  Gut       Date:  2012-01-22       Impact factor: 23.059

2.  Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.

Authors:  M Ocker; D Neureiter; M Lueders; S Zopf; M Ganslmayer; E G Hahn; C Herold; D Schuppan
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 3.  The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.

Authors:  M R Moniri; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

Review 4.  Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.

Authors:  Kenneth W Hance; Hasan E Zeytin; John W Greiner
Journal:  Mutat Res       Date:  2005-08-25       Impact factor: 2.433

5.  Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.

Authors:  Howard C Crawford; Charles R Scoggins; M Kay Washington; Lynn M Matrisian; Steven D Leach
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

6.  KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations.

Authors:  Rónán C O'Hagan; Joerg Heyer
Journal:  Genes Cancer       Date:  2011-03

7.  PTEN loss accelerates KrasG12D-induced pancreatic cancer development.

Authors:  Reginald Hill; Joseph Hargan Calvopina; Christine Kim; Ying Wang; David W Dawson; Timothy R Donahue; Sarah Dry; Hong Wu
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

8.  Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

Authors:  Susana Aguilar; Josep M Corominas; Núria Malats; José A Pereira; Marlène Dufresne; Francisco X Real; Pilar Navarro
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

9.  Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study.

Authors:  Joseph R Habib; Yayun Zhu; Lingdi Yin; Ammar A Javed; Ding Ding; Jonathan Tenior; Michael Wright; Syed Z Ali; Richard A Burkhart; William Burns; Christopher L Wolfgang; Eunji Shin; Jun Yu; Jin He
Journal:  J Gastrointest Surg       Date:  2021-07-09       Impact factor: 3.452

10.  p16(INK4A) positively regulates p21(WAF1) expression by suppressing AUF1-dependent mRNA decay.

Authors:  Huda H Al-Khalaf; Abdelilah Aboussekhra
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.